SCHEMBL9996385

SCHEMBL9996385

[CH]=Cc1ccc(Cl)cc1C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR1 Q9BXC0 1/20 0.39
RAB9A P51151 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
GRIK1 P39086 1/20 0.37
TDP1 Q9NUW8 2/20 0.36
PKM P14618 1/20 0.36
PTP4A3 O75365 1/20 0.36
APP P05067 1/20 0.36
AR P10275 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HSD11B1 P28845 2/20 0.35
GLA P06280 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TNF P01375 1/20 0.33
NOD1 Q9Y239 1/20 0.33
POLQ O75417 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL502871 0.80 TDP1 (0.55) HCAR1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL9996387 0.80 HCAR1 (0.39) HCAR1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL9996772 0.78 CES2 (0.46) HCAR1PKMAPPARKDM4E
SCHEMBL7806209 0.76 HPGD (0.44) HCAR1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL1720266 0.76 PDE3B (0.44) HCAR1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL7806207 0.76 HPGD (0.44) HCAR1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL2634025 0.76 MAOB (0.42) HCAR1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL28240259 0.74 TDP1 (0.40) HCAR1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL3789153 0.73 CYP3A4 (0.52) HCAR1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL9996581 0.72 TDP1 (0.40) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895565-B2 Heterocyclic compound and use of the same NISHIO TETSUYA (JP) 2014-11-25 US disclosed
US-20110319618-A1 HETEROCYCLIC COMPOUND AND USE OF THE SAME NISHIO TETSUYA (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319618-A1 HETEROCYCLIC COMPOUND AND USE OF THE SAME CYP2D6, CYP2B6, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 HCAR1 1348/4885RAB9A 683/4885CYP1A2 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.